Equities

Allergy Therapeutics PLC

Allergy Therapeutics PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)5.20
  • Today's Change0.00 / 0.00%
  • Shares traded215.09k
  • 1 Year change+188.89%
  • Beta1.9163
Data delayed at least 20 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in GBX

The one analyst offering a 12 month price target expects Allergy Therapeutics plc share price to rise to 13.00 in the next year from the last price of 5.20.
High150.0%13.00
Med150.0%13.00
Low150.0%13.00

Earnings history & estimates in GBX

Allergy Therapeutics plc reported annual 2024 losses of -1.07 per share on Nov 06, 2024.
Average growth rate-53.14%
More ▼

Revenue history & estimates in GBP

Allergy Therapeutics plc had revenues for the full year 2024 of 55.20m. This was 9.44% below the prior year's results.
Average growth rate-7.89%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.